Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Microvascular Obstruction (MVO)STEMI - ST Elevation Myocardial Infarction
Interventions
DEVICE

CorFlow Controlled Flow Infusion System - CoFI™

The CorFlow CoFI™ System is intended to assess the dynamic microvascular resistance and to treat microvascular obstruction in the coronary vasculature of patients following PCI with stent placement.

Sponsors
All Listed Sponsors
lead

CorFlow Therapeutics AG

INDUSTRY

NCT06909578 - Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II | Biotech Hunter | Biotech Hunter